From the JDD Podcast Vault: Evidence-Based Framing for Improving Treatment Adherence
Welcome to our newest blog series, From the JDD Podcast Vault, where we spotlight standout episodes from the JDD Dermatology Podcast, hosted by the always-engaging Dr. Adam Friedman. Each post will revisit compelling conversations that continue to educate, inspire, and provoke thought in dermatologic practice.
In this featured episode, “Wondering About Words: Evidence-Based Framing for Improvin …
Welcome to our newest blog series, From the JDD Podcast Vault, where we spotlight standout episodes from the JDD Dermatology Podcast, hosted by the always-engaging Dr. Adam Friedman. Each post will revisit compelling conversations that continue to educate, inspire, and provoke thought in dermatologic practice.
In this featured episode, “Wondering About Words: Evidence-Based Framing for Improvin … 
Atopic dermatitis and prurigo nodularis are chronic, life-altering diseases with a common feature of debilitating pruritus that significantly impacts our patients’ qualities of life. For those with resistant and extensive disease, dermatologists now have nemolizumab in our armamentarium, the first FDA approved IL-31 inhibitor. We continue our series, Therapeutic Cheat Sheet, with a closer look a … 
Pigmentary distress impacts people of all skin types, according to Dr. Gilly Munavalli, associate clinical professor of dermatology at Wake Forest University School of Medicine. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Munavalli shares how to use lasers and energy-based devices to treat pigmentary disorders. Find out what Dr. Munaval … 